SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "WFRF:(Lannfelt Lars) ;pers:(Glaser Anna)"

Search: WFRF:(Lannfelt Lars) > Glaser Anna

  • Result 1-10 of 16
Sort/group result
   
EnumerationReferenceCoverFind
1.
  • Giedraitis, Vilmantas, et al. (author)
  • CALHM1 P86L polymorphism does not alter amyloid-beta or tau in cerebrospinal fluid
  • 2010
  • In: Neuroscience Letters. - : Elsevier BV. - 0304-3940 .- 1872-7972. ; 469:2, s. 265-267
  • Journal article (peer-reviewed)abstract
    • Recently, the P86L alteration in CALHM1 (calcium homeostasis modulator-1) was reported to be associated with Alzheimer's disease (AD). Moreover, the risk allele increased amyloid-beta (A beta) levels in conditioned media from cultured cells. Therefore, we hypothesized that CALHM1 P86L may modulate A beta or tau levels in cerebrospinal fluid (CSF). Nearly 200 individuals with AD or other cognitive disorders were included for CSF analysis and CALHM1 genotyping. No significant differences in CSF levels of A beta 42, tau or phospho-tau were found across the various CALHM1 genotypes. In conclusion, we found no evidence that CALHM1 P86L is associated with altered CSF levels of the investigated AD biomarkers.
  •  
2.
  • Blom, Elin, 1979- (author)
  • Genetic Studies of Alzheimer's Disease
  • 2008
  • Doctoral thesis (other academic/artistic)abstract
    • Patients with Alzheimer's disease (AD) often have a family history of the disease, implicating genetics as a major risk factor. Three genes are currently known to cause familial early-onset AD (<65 years): the amyloid precursor protein (APP) and the presenilins (PSEN1 and PSEN2). For the much more common late-onset disease (>65 years), only the APOE gene has repeatedly been associated to AD, where the ε4 allele increases disease risk and decreases age at onset. As APOE ε4 only explains part of the total estimated disease risk, more genes are expected to contribute to AD.This thesis has focused on the study of genetic risk factors involved in AD. In the first study, we conducted a linkage analysis of six chromosomes previously implicated in AD in a collection of affected relative pairs from Sweden, the UK and the USA. An earlier described linkage peak on chromosome 10q21 could not be replicated in the current sample, while significant linkage was demonstrated to chromosome 19q13 where the APOE gene is located. The linkage to 19q13 was further analyzed in the second study, demonstrating no significant evidence of genes other than APOE contributing to this peak. In the third study, the prevalence of APP duplications, a recently reported cause of early-onset AD, was investigated. No APP duplications were identified in 141 Swedish and Finnish early-onset AD patients, implying that this is not a common disease mechanism in the Scandinavian population. In the fourth study, genes with altered mRNA levels in the brain of a transgenic AD mouse model (tgAPP-ArcSwe) were identified using microarray analysis. Differentially expressed genes were further analyzed in AD brain. Two genes from the Wnt signaling pathway, TCF7L2 and MYC, had significantly increased mRNA levels in both transgenic mice and in AD brains, implicating cell differentiation and possibly neurogenesis in AD.
  •  
3.
  • Blom, Elin Susanne, et al. (author)
  • Does APOE explain the linkage of Alzheimer’s disease to chromosome 19q13?
  • 2008
  • In: American Journal of Medical Genetics Part B: Neuropsychiatric Genetics American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. - : Wiley. - 1552-485X. ; 147B:6, s. 778-83
  • Journal article (peer-reviewed)abstract
    • We have studied the impact of the apolipoprotein E gene (APOE) on the chromosome 19 linkage peak from an analysis of sib-pairs affected by Alzheimer's disease. We genotyped 417 affected sib-pairs (ASPs) collected in Sweden and Norway (SWE), the UK and the USA for 10 microsatellite markers on chromosome 19. The highest Zlr (3.28, chromosome-wide P-value 0.036) from the multi-point linkage analysis was located approximately 1 Mb from APOE, at marker D19S178. The linkage to chromosome 19 was well explained by APOE in the whole sample as well as in the UK and USA subsamples, as identity by descent (IBD) increased with the number of epsilon 4 alleles in ASPs. There was a suggestion from the SWE subsample that linkage was higher than would be expected from APOE alone, although the test for this did not reach formal statistical significance. There was also a significant age at onset (aao) effect on linkage to chromosome 19q13 in the whole sample, which manifested itself as increased IBD sharing in relative pairs with lower mean aao. This effect was partially, although not completely, explained by APOE. The aao effect varied considerably between the different subsamples, with most of the effect coming from the UK sample. The other samples showed smaller effects in the same direction, but these were not significant.
  •  
4.
  • Blom, Elin Susanne, et al. (author)
  • Further analysis of previously implicated linkage regions for Alzheimer’s disease in affected relative pairs
  • 2009
  • In: BMC Medical Genetics. - : Springer Science and Business Media LLC. - 1471-2350. ; 10, s. 122-
  • Journal article (peer-reviewed)abstract
    • Background: Genome-wide linkage studies for Alzheimer's disease have implicated several chromosomal regions as potential loci for susceptibility genes. Methods: In the present study, we have combined a selection of affected relative pairs (ARPs) from the UK and the USA included in a previous linkage study by Myers et al. (Am J Med Genet, 2002), with ARPs from Sweden and Washington University. In this total sample collection of 397 ARPs, we have analyzed linkage to chromosomes 1, 9, 10, 12, 19 and 21, implicated in the previous scan. Results: The analysis revealed that linkage to chromosome 19q13 close to the APOE locus increased considerably as compared to the earlier scan. However, linkage to chromosome 10q21, which provided the strongest linkage in the previous scan could not be detected. Conclusion: The present investigation provides yet further evidence that 19q13 is the only chromosomal region consistently linked to Alzheimer's disease.
  •  
5.
  • Blom, Elin Susanne, et al. (author)
  • Low prevalence of APP duplications in Swedish and Finnish patients with early onset Alzheimer's disease
  • 2008
  • In: European Journal of Human Genetics. - : Springer Science and Business Media LLC. - 1018-4813 .- 1476-5438. ; 16:2, s. 171-5
  • Journal article (peer-reviewed)abstract
    • Familial early-onset Alzheimer's disease with cerebral amyloid angiopathy (EOAD/CAA) was recently associated with duplications of the gene for the amyloid-beta precursor protein (APP). In this study, we have screened for duplications of APP in patients with EOAD from Sweden and Finland. Seventy-five individuals from families with EOAD and 66 individuals with EOAD without known familial inheritance were screened by quantitative PCR. On the basis of the initial results, a portion of the samples was also investigated with quantitative multiplex PCR. No duplications of APP were identified, whereby we conclude that this is not a common cause of EOAD in the Swedish and Finnish populations, at least not in our collection of families and cases.
  •  
6.
  •  
7.
  • Giedraitis, Vilmantas, et al. (author)
  • Genetic analysis of Alzheimer's disease in the Uppsala Longitudinal Study of Adult Men
  • 2009
  • In: Dementia and Geriatric Cognitive Disorders. - : S. Karger AG. - 1420-8008 .- 1421-9824. ; 27:1, s. 59-68
  • Journal article (peer-reviewed)abstract
    • BACKGROUND/AIMS: Genetic factors influencing common complex conditions have proven difficult to identify, and data from numerous investigations have provided incomplete conclusions as to the identity of these genes. Here we aimed to identify susceptibility genes for late-onset Alzheimer's disease (AD). METHODS: The case-control analysis included samples from 86 AD patients and 404 cognitively healthy controls selected from the Uppsala Longitudinal Study of Adult Men (ULSAM). In the incidence analysis, all 1,088 genotyped ULSAM participants were included. DNA samples from ULSAM participants were analyzed for 2,578 single nucleotide polymorphisms (SNP) within 368 genes. The selection of genes tested for association to AD within this cohort was based on genes previously implicated in conditions with relevance to ULSAM, such as dementia, cardiovascular disease, diabetes and metabolic syndrome, osteoporosis, and cancer. RESULTS/CONCLUSION: Association analysis revealed 82 genes containing at least 1 significant SNP at p < 0.05 with association to AD. Only 20 genes remained significant after a permutation test to correct for multiple comparisons within individual genes. Using publicly available data from 2 genome-wide association (GWA) studies and linkage disequilibrium data from HapMap, we attempted to replicate the AD association identified in ULSAM. In addition to apolipoprotein E, we were able to replicate 5 other genes in both GWA studies at p < 0.05.
  •  
8.
  • Giedraitis, Vilmantas, et al. (author)
  • New Alzheimer's disease locus on chromosome 8
  • 2006
  • In: Journal of Medical Genetics. - : BMJ. - 0022-2593 .- 1468-6244. ; 43:12, s. 931-935
  • Journal article (peer-reviewed)abstract
    • Background: Family history is one of the most consistent risk factors for dementia. Therefore, analysis of families with a distinct inheritance pattern of disease can be a powerful approach for the identification of previously unknown disease genes. Objective: To map susceptibility regions for Alzheimer's disease. Methods: A complete genome scan with 369 microsatellite markers was carried out in 12 extended families collected in Sweden. Age at disease onset ranged from 53 to 78 years, but in 10 of the families there was at least one member with age at onset of <= 65 years. Mutations in known early-onset Alzheimer's disease susceptibility genes have been excluded. All people were genotyped for APOE, but no clear linkage with the epsilon 4 allele was observed. Results: Although no common disease locus could be found in all families, in two families an extended haplotype was identified on chromosome 8q shared by all affected members. In one of the families, a non-parametric multi-marker logarithm of the odds (LOD) score of 4.2 (p = 0.004) was obtained and analysis based on a dominant model showed a parametric LOD score of 2.4 for this region. All six affected members of this family shared a haplotype of 10 markers spanning about 40 cM. Three affected members in another family also shared a haplotype in the same region. Conclusion: On the basis of our data, we propose the existence of a dominantly acting Alzheimer's disease susceptibility locus on chromosome 8.
  •  
9.
  • Santillo, Alexander, et al. (author)
  • Frontotemporal Dementia-amyotrophic Lateral Sclerosis Complex is Simulated by Neurodegeneration With Brain Iron Accumulation
  • 2009
  • In: Alzheimer Disease and Associated Disorders. - 0893-0341 .- 1546-4156. ; 23:3, s. 298-300
  • Journal article (peer-reviewed)abstract
    • We describe a case of late onset neurodegeneration with brain iron accumulation (NBIA) presenting as frontotemporal dementia (FTD) with amyotrophic lateral sclerosis (ALS). A male patient presented at age 66 with change of personality: disinhibition, emotional blunting, and socially inappropriate behavior, coupled with dysarthria, dystonia, and corticospinal tract involvement. Magnetic resonance imaging showed general cortical atrophy, iron deposits in the globus pallidus, and the "eye of the tiger" sign. Neuropsychologic performance was globally reduced, especially executive functions. Fluorodeoxyglucose positron emission tomography showed hypometabolism predominantly in frontal and temporal areas. Repeated neurophysiologic examinations showed signs of chronic denervation. The patient was diagnosed with NBIA but fulfilled consensus criteria for FTD and had a clinical picture of ALS, without neurophysiologic confirmation. Our finding introduces NBIA as a possible cause of FTD and as a differential diagnosis of the FTD-ALS complex.
  •  
10.
  • Skoglund, Lena, et al. (author)
  • Frontotemporal dementia in a large Swedish family is caused by a progranulin null mutation
  • 2009
  • In: Neurogenetics. - : Springer Science and Business Media LLC. - 1364-6745 .- 1364-6753. ; 10:1, s. 27-34
  • Journal article (peer-reviewed)abstract
    • Mutations in the progranulin (PGRN) gene have recently been identified in families with frontotemporal lobar degeneration and ubiquitin-positive brain inclusions linked to chromosome 17q21. We have previously described a Swedish family displaying frontotemporal dementia with rapid progression and linkage to chromosome 17q21. In this study, we performed an extended clinical and neuropathological investigation of affected members of the family and a genetic analysis of the PGRN gene. There was a large variation of the initial presenting symptoms in this family, but common clinical features were non-fluent aphasia and loss of spontaneous speech as well as personality and behavioural changes. Mean age at onset was 54 years with disease duration of close to 4 years. Neuropathological examination revealed frontotemporal neurodegeneration with ubiquitin and TAR DNA binding protein-43 immunoreactive intraneuronal inclusions. Mutation screening of the PGRN gene identified a 1 bp deletion in exon 1 causing a frameshift of the coding sequence and introducing a premature termination codon in exon 2 (Gly35GlufsX19). Analysis of PGRN messenger RNA (mRNA) levels revealed a considerable decrease in lymphoblasts from mutation carriers and fragment size separation, and sequence analysis confirmed that the mutated mRNA allele was almost absent in these samples. In conclusion, the PGRN Gly35fs mutation causes frontotemporal dementia with variable clinical presentation in a large Swedish family, most likely through nonsense-mediated decay of mutant PGRN mRNA and resulting haploinsufficiency.
  •  
Skapa referenser, mejla, bekava och länka
  • Result 1-10 of 16
Type of publication
journal article (13)
doctoral thesis (2)
other publication (1)
Type of content
peer-reviewed (13)
other academic/artistic (3)
Author/Editor
Lannfelt, Lars (14)
Ingelsson, Martin (8)
Skoglund, Lena (8)
Giedraitis, Vilmanta ... (7)
Kilander, Lena (6)
show more...
Blom, Elin Susanne (3)
Kalimo, Hannu (2)
Basun, Hans (2)
Arepalli, Sampath (2)
Hiltunen, Mikko (2)
Soininen, Hilkka (2)
Hardy, John (2)
Lindau, Maria (2)
Glaser, Anna, PhD (2)
Ingelsson, Martin, M ... (2)
Lannfelt, Lars, MD (2)
Adighibe, Omanma (2)
Hamshere, Marian L. (2)
Goate, Alison (2)
Williams, Julie (2)
Wavrant-De Vrièze, F ... (2)
Blom, Elin S (2)
Wallin, Anders, 1950 (1)
Axelsson, Tomas (1)
Syvänen, Ann-Christi ... (1)
Hedlund, M. (1)
Viitanen, Matti (1)
Pedersen, Nancy L (1)
Van Broeckhoven, Chr ... (1)
Thal, Dietmar R (1)
Daniilidou, Makrina (1)
Gatz, Margaret (1)
Eriksdotter-Jönhagen ... (1)
Engelborghs, Sebasti ... (1)
Santillo, Alexander (1)
Wallin, Anders (1)
Bertram, Lars (1)
Sleegers, Kristel (1)
Żekanowski, Cezary (1)
Tanzi, Rudolph E. (1)
Hyman, Bradley T (1)
Hock, Christoph (1)
Nitsch, Roger M. (1)
Blom, Elin, 1979- (1)
Hillert, Jan, Profes ... (1)
Holmans, Peter (1)
Bergem, A. L. Mina (1)
Owen, Michael J. (1)
Hollingworth, Paul (1)
show less...
University
Uppsala University (16)
Högskolan Dalarna (7)
Karolinska Institutet (2)
University of Gothenburg (1)
Language
English (15)
Undefined language (1)
Research subject (UKÄ/SCB)
Medical and Health Sciences (8)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view